| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Calliditas Therapeutics AB (publ) (F: LC8A)
LC8A Technical Analysis
5
| As on 30th Sep 2024 LC8A STOCK Price closed @ 35.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 17.50 & Strong Buy for SHORT-TERM with Stoploss of 17.31 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LC8ASTOCK Price
| Open | 35.00 | Change | Price | % |
| High | 35.00 | 1 Day | -0.40 | -1.13 |
| Low | 35.00 | 1 Week | 0.00 | 0.00 |
| Close | 35.00 | 1 Month | -0.20 | -0.57 |
| Volume | N/A | 1 Year | 14.20 | 68.27 |
| 52 Week High 38.00 | 52 Week Low 13.90 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| LC8A Daily Charts |
LC8A Intraday Charts |
Whats New @ Bazaartrend |
LC8A Free Analysis |
|
|
LC8A Important Levels Intraday
| RESISTANCE | 35.00 |
| RESISTANCE | 35.00 |
| RESISTANCE | 35.00 |
| RESISTANCE | 35.00 |
| RESISTANCE | 35.00 |
| RESISTANCE | 35.00 |
| RESISTANCE | 35.00 |
| RESISTANCE | 35.00 |
LC8A Forecast March 2026
| 4th UP Forecast | 40.2 |
| 3rd UP Forecast | 38.53 |
| 2nd UP Forecast | 37.5 |
| 1st UP Forecast | 36.47 |
| 1st DOWN Forecast | 33.53 |
| 2nd DOWN Forecast | 32.5 |
| 3rd DOWN Forecast | 31.47 |
| 4th DOWN Forecast | 29.8 |
LC8A Weekly Forecast
| 4th UP Forecast | 38.47 |
| 3rd UP Forecast | 37.36 |
| 2nd UP Forecast | 36.67 |
| 1st UP Forecast | 35.98 |
| 1st DOWN Forecast | 34.02 |
| 2nd DOWN Forecast | 33.33 |
| 3rd DOWN Forecast | 32.64 |
| 4th DOWN Forecast | 31.53 |
LC8A Forecast2026
| 4th UP Forecast | 81.44 |
| 3rd UP Forecast | 66.55 |
| 2nd UP Forecast | 57.34 |
| 1st UP Forecast | 48.13 |
| 1st DOWN Forecast | 21.87 |
| 2nd DOWN Forecast | 12.66 |
| 3rd DOWN Forecast | 3.45 |
| 4th DOWN Forecast | -11.44 |
Calliditas Therapeutics AB (publ) ( F Germany Symbol : LC8A )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LC8A Business Profile
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. The company's lead product candidate is Nefecon, a oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden. Address: Kungsbron 1, C8, Stockholm, Sweden, 111 22
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service